Daan Biotherapeutics

Developer of therapeutics for cancer treatment

placeSeoul, Seoul, South Korea calendar_todayFounded 2020 groups4 employees language daanbiotpx.com

Investor mix

11 investors on record; lead investors include Solasta Ventures, Company K Partners, Paratus Investment, Atinum Investment.

Investor typeCountShare
Venture capital655%
Private equity327%
Bank & private debt19%
Other / undisclosed19%
Coming soon